Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$2.08M Sell
27,666
-4,573
-14% -$348K 0.77% 44
2021
Q2
$2.51M Sell
32,239
-1,698
-5% -$126K 0.93% 37
2021
Q1
$2.5M Sell
33,937
-1,344
-4% -$99.1K 0.77% 44
2020
Q4
$2.75M Sell
35,281
-428
-1% -$32.7K 0.92% 38
2020
Q3
$2.83M Buy
35,709
+1,786
+5% +$140K 1.13% 25
2020
Q2
$2.5M Buy
33,923
+72
+0.2% +$5.42K 1.12% 30
2020
Q1
$2.48M Buy
33,851
+568
+2% +$44.6K 1.35% 22
2019
Q4
$2.89M Buy
33,283
+298
+0.9% +$24.5K 1.16% 27
2019
Q3
$2.65M Sell
32,985
-1,287
-4% -$103K 1.15% 26
2019
Q2
$2.74M Sell
34,272
-157
-0.5% -$12K 1.22% 23
2019
Q1
$2.73M Sell
34,429
-11
-0% -$823 1.25% 24
2018
Q4
$2.51M Sell
34,440
-238
-0.7% -$16.8K 1.3% 23
2018
Q3
$2.35M Buy
34,678
+131
+0.4% +$8.35K 1.05% 33
2018
Q2
$2M Buy
34,547
+265
+0.8% +$14.9K 0.94% 38
2018
Q1
$1.78M Buy
34,282
+52
+0.2% +$2.81K 0.87% 42
2017
Q4
$1.84M Buy
34,230
+3,295
+11% +$183K 0.86% 39
2017
Q3
$1.89M Sell
30,935
-1,655
-5% -$100K 1.1% 32
2017
Q2
$1.99K Sell
32,590
-2,286
-7% -$139K 1.02% 29
2017
Q1
$2.12M Buy
+34,876
New +$2.12M 1.08% 30
2015
Q2
$1.86M Buy
+34,340
New +$1.93M 1.17% 26
2014
Q4
$2.3M Sell
42,486
-598
-1% -$33.3K 0.8% 43
2014
Q3
$2.44M Sell
43,084
-1,054
-2% -$59.2K 0.9% 34
2014
Q2
$2.44M Sell
44,138
-82
-0.2% -$4.47K 0.9% 40
2014
Q1
$2.4M Buy
44,220
+3,459
+8% +$179K 0.94% 40
2013
Q4
$1.95M Sell
40,761
-83
-0.2% -$3.79K 0.8% 45
2013
Q3
$1.85M Buy
40,844
+530
+1% +$24.2K 0.74% 44
2013
Q2
$1.79M Buy
+40,314
New +$1.8M 0.75% 46

Other funds holding MRK

FMA Advisory's MRK Position: Q3 2021 in Review

FMA Advisory reduced its Merck (MRK) stake by 14% in Q3 2021, selling an estimated $348K and leaving 27,666 shares worth $2.08M. The position accounts for 0.77% of the portfolio, ranked #44.

FMA Advisory first reported a position in MRK in Q2 2013 and has held it in 27 quarters since. The position peaked at $2.89M in Q4 2019. 2,647 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

  • FMA Advisory held 27,666 shares of Merck worth $2.08M as of Q3 2021.
  • FMA Advisory sold 4,573 Merck shares in Q3 2021, an estimated $348K.
  • Merck made up 0.77% of FMA Advisory's portfolio in Q3 2021, its #44 holding.
  • FMA Advisory first reported a position in Merck in Q2 2013 and has held it in 27 quarters since.
  • FMA Advisory's Merck position peaked at $2.89M in Q4 2019.
  • 2,647 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on FMA Advisory's 13F filing for Q3 2021, filed 15 Nov 2021.